Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases (IBDs) are complex, multifactorial disorders characterized by chronic relapsing intestinal inflammation. Although etiology remains largely unknown, recent research has suggested that genetic factors, environment, microbiota, and immune response are involved in the pathogenesis. Epidemiological evidence for a genetic contribution is defined: 15% of patients with Crohn's Disease (CD) have an affected family member with IBD, and twin studies for CD have shown 50% concordance in monozygotic twins compared to <10% in dizygotics. The most recent and largest genetic association studies, which employed genome-wide association data for over 75,000 patients and controls, identified 163 susceptibility loci for IBD. More recently, a trans-ethnic analysis, including over 20,000 individuals, identified an additional 38 new IBD loci. Although most cases are correlated with polygenic contribution toward genetic susceptibility, there is a spectrum of rare genetic disorders that can contribute to early-onset IBD (before 5 years) or very early onset IBD (before 2 years). Genetic variants that cause these disorders have a wide effect on gene function. These variants are so rare in allele frequency that the genetic signals are not detected in genome-wide association studies of patients with IBD. With recent advances in sequencing techniques, ~50 genetic disorders have been identified and associated with IBD-like immunopathology. Monogenic defects have been found to alter intestinal immune homeostasis through many mechanisms. Candidate gene resequencing should be carried out in early-onset patients in clinical practice. The evidence that genetic factors contribute in small part to disease pathogenesis confirms the important role of microbial and environmental factors. Epigenetic factors can mediate interactions between environment and genome. Epigenetic mechanisms could affect development and progression of IBD. Epigenomics is an emerging field, and future studies could provide new insight into the pathogenesis of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Cooney, R., Baker, J., Brain, O., Danis, B., Pichulik, T., Allan, P., Ferguson, D. J. P., Campbell, B. J., Jewell, D., & Simmons, A. (2010) · Nature Medicine · doi:10.1038/nm.2069 · Cited by 1,047
The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease
Uhlig, H. H., Schwerd, T., Koletzko, S., Shah, N., Kammermeier, J., Elkadri, A., Ouahed, J., Wilson, D. C., Travis, S. P., Turner, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.023 · Cited by 715
Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., Serpe, J. M., Dasu, T., Tschannen, M. R., Veith, R. L., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182088158 · Cited by 711
Genomic analysis of human microRNA transcripts
Saini, H. K., Griffiths-Jones, S., & Enright, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703890104 · Cited by 554
Disease gene identification strategies for exome sequencing
Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.258 · Cited by 460
Genetics of Inflammatory Bowel Diseases
McGovern, D. P. B., Kugathasan, S., & Cho, J. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.001 · Cited by 431
Recent Insights Into the Genetics of Inflammatory Bowel Disease
Cho, J. H., & Brant, S. R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.046 · Cited by 425
Uhlig, H. H. (2013) · Gut · doi:10.1136/gutjnl-2012-303956 · Cited by 335
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
Ventham, N. T., Kennedy, N. A., Nimmo, E. R., & Satsangi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.050 · Cited by 320
Interleukin 10 Receptor Signaling
Shouval, D. S., Ouahed, J., Biswas, A., Goettel, J. A., Horwitz, B. H., Klein, C., Muise, A. M., & Snapper, S. B. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00005-5 · Cited by 304
Infant colitis—it's in the genes
Glocker, E.-O., Frede, N., Perro, M., Sebire, N., Elawad, M., Shah, N., & Grimbacher, B. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61008-2 · Cited by 268
Kalla, R., Ventham, N. T., Kennedy, N. A., Quintana, J. F., Nimmo, E. R., Buck, A. H., & Satsangi, J. (2015) · Gut · doi:10.1136/gutjnl-2014-307891 · Cited by 267
Unlocking Mendelian disease using exome sequencing
Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2011) · Genome Biology · doi:10.1186/gb-2011-12-9-228 · Cited by 266
New genes in inflammatory bowel disease: lessons for complex diseases?
Gaya, D. R., Russell, R. K., Nimmo, E. R., & Satsangi, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68345-1 · Cited by 245
The usefulness of whole-exome sequencing in routine clinical practice
Iglesias, A., Anyane-Yeboa, K., Wynn, J., Wilson, A., Truitt Cho, M., Guzman, E., Sisson, R., Egan, C., & Chung, W. K. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.58 · Cited by 237
MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response
Iborra, M., Bernuzzi, F., Invernizzi, P., & Danese, S. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.002 · Cited by 178
The emerging role of miRNAs in inflammatory bowel disease: a review
Chapman, C. G., & Pekow, J. R. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14547360 · Cited by 173
The Role of MicroRNA in Inflammatory Bowel Disease.
Dalal, S. R., & Kwon, J. H. (2010) · PubMed Central · Cited by 151
Genome-wide association studies: a new window into immune-mediated diseases
Xavier, R. J., & Rioux, J. D. (2008) · Nature Reviews Immunology · doi:10.1038/nri2361 · Cited by 140
Pigneur, B., Escher, J. C., Elawad, M., Lima, R., Buderus, S., Kierkuś, J., Guariso, G., Canioni, D., Lambot, K., Talbotec, C., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435439.22484.d3 · Cited by 102
MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics
Coskun, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i34.4629 · Cited by 91
Practical considerations in the clinical application of whole‐exome sequencing
Shashi, V., McConkie‐Rosell, A., Schoch, K., Kasturi, V. G., Rehder, C. W., Jiang, Y., Goldstein, D. B., & McDonald, M. (2015) · Clinical Genetics · doi:10.1111/cge.12569 · Cited by 69
Epigenetic Alterations in Inflammatory Bowel Disease and Cancer
Yi, J. M., & Kim, T. O. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.2.112 · Cited by 37
Cited by
The role of inflammation and genetics in periodontal disease
Loos, B. G., & Van Dyke, T. E. (2020) · Periodontology 2000 · doi:10.1111/prd.12297 · Cited by 612
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., Sánchez-Martinez, H., & Gonzalez-Granado, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021526 · Cited by 580
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease
Weingarden, A. R., & Vaughn, B. P. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1290757 · Cited by 463
Nutrition, IBD and Gut Microbiota: A Review
Mentella, M. C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A., & Miggiano, G. A. D. (2020) · Nutrients · doi:10.3390/nu12040944 · Cited by 340
Tong, L.-C., Wang, Y., Wang, Z.-B., Liu, W.-Y., Sun, S., Li, L., Su, D.-F., & Zhang, L.-C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00253 · Cited by 331
Metadata
- Authors
- Loddo, I., & Romano, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-11-02
- Volume
- 6
- Pages
- 551-551
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2194307286
- Cited by
- 449
- References
- 26
- FWCI
- 20.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.